Table 8.
Covid-19 vaccines approved (emergency use authorization) in the investigated cities and provinces (date of approval# in dd/mm/yy format).
| Cities/Provinces | mRNA based |
Non-replicating viral vector |
Inactivated |
|||||
|---|---|---|---|---|---|---|---|---|
| Pfizer/BioNTech Comirnaty | Moderna Spikevax | AstraZeneca/Oxford Vaxzervriab | J&J Janssen | Gamaleya Sputnik Vc | Sinopharm Covilo | SinoVac CoronaVac | Bharat Biotech Covaxin | |
| Bangkok | 24.06.21 | 13.05.21 | 20.01.21 | 25.03.21 | Pendinga | 28.05.21 | 22.02.21 | Pendinga |
| Gauteng | 16.03.21 | Pendinga | 23.01.21 | 22.02.21 | Unknowna | 07.02.21 | 03.07.21 | Unknowna |
| Ho Chi Minh City‡ | 12.06.21 | 29.06.21 | 29.01.21 | 15.07.21 | 23.03.21 | 04.06.21 | Unknowna | 10.11.21 |
| Jakarta$ | 15.07.21 | 02.07.21 | 09.03.21 | 07.09.21 | 24.08.21 | 30.04.21 | 11.01.21 | Unknowna |
| London | 02.12.20 | 08.01.21 | 30.12.20 | 28.05.21 | Unknowna | Unknowna | Unknowna | Unknowna |
| Manila NCR‡ | 11.03.21 | 05.05.21 | 28.01.21 | 20.04.21 | 19.03.21 | 08.06.21 | 07.04.21 | 20.04.21 |
| New Delhi† | Unknowna | 29.06.21 | 03.01.21 | 07.08.21 | 13.04.21 | Unknowna | Unknowna | 03.01.21 |
| New York City | 11.12.20 | 19.12.20 | Pendinga | 27.02.21 | Unknowna | Unknowna | Unknowna | Pendinga |
| Singapore | 14.12.20 | 03.02.21 | Unknowna | Unknowna | Unknowna | Unknowna | 23.10.21 | Unknowna |
| Tokyo | 15.02.21 | 21.05.21 | 21.05.21 | Unknowna | Unknowna | Unknowna | Unknowna | Unknowna |
Note that date of approval of vaccine doesn't indicate that the vaccine was made available for use for public. Additionally, date of approval doesn't correspond to the date of start of administration of vaccine. The date of approval is representative for the entire country and for adult populations (Source: https://covid19.trackvaccines.org/). The date of approval may vary by 1-2 days from official government sources (due to variations in news reporting and official dates).
Pending status indicates that the vaccine had not approved been approved in the period studied in the present study (up to November 2021). Unknown status indicates no information is available regarding the application status and approval status for emergency use authorization in the country.
AstraZeneca/Oxford Vaxzevria also includes its analogue produced by Serum Institute of India Covishield.
Gamaleya Sputnik V doesn't include the later developed Sputnik Light.
Vietnam (Ho Chi Minh City) had also approved Center for Genetic Engineering and Biotechnology (CIGB) Abdala on 18.09.21.
Indonesia (Jakarta) had also approved Anhui Zhifei Longcom Zifivax on 07.10.21, Serum Institute of India COVOVAX on 01.11.2021, CanSino Convidecia on 07.09.21 and BioKangtai KconecaVac on 31.10.21.
India (New Delhi) had also approved Zydus Cadila ZyCoV-D on 20.08.21 and Sputnik Light on 17.05.21.
‡Philippines (Manila NCR) had also approved Sputnik Light on 23.08.21 and Serum Institute of India COVOVAX on 17.11.21.